Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Britomar vs Diuver in Arterial Hypertension and Chronic Heart Failure
NCT02087332Phase 4Unknown
- Sponsor
- Society of Specialists in Heart Failure
- Start
- Apr 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of Britomar in hypertension (HTN) and chronic heart failure (CHF) (2 arms), sponsored by Society of Specialists in Heart Failure. Primary endpoint: Inflammatory markers excretion at 3 months. Status: unknown.
02
Drugs
Britomar
03
Conditions
hypertension (HTN)chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT02087332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02087332.